186
Participants
Start Date
March 31, 2015
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Mitroflow DL
Treatment with Mitroflow Pericardial Aortic Heart Valve with Phospholipid Reduction Therapy (Model DL)
Lankenau Medical Center, Wynnewood
Suburban Hospital - John Hopkins Medicine, Bethesda
University of Virginia Medical Center, Charlottesville
Duke University Medical Center, Durham
River City Clinical Research, Jacksonville
UF Health - Jacksonville, Jacksonville
Watson Clinic Center for Research, Lakeland
St. John Hospital & Medical Center, Detroit
Bay Regional Medical Center, Bay City
UCLA Medical Center, Los Angeles
Sharp Memorial Hospital, San Diego
Catholic Medical Center, Manchester
St. Joseph's Regional Medical Center, Paterson
Lead Sponsor
LivaNova
INDUSTRY